Skip to content

The Comparison Effect Of ondansetron and Ginger on Postoperative Nausea And Vomiting after Ophthalmic Surgery

The Comparison Effect Of ondansetron and Ginger on Incidence and Severity of Postoperative Nausea and Vomiting in Patients Undertaken Ophthalmic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014060918020N1
Enrollment
150
Registered
2014-07-02
Start date
2014-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Glaucoma. Condition 2: Paralytic strabismus. Condition 3: cataract. Glaucoma Paralytic strabismus capsular glaucoma with pseudoexfoliation of lens

Interventions

Intervention 1: Intervention 1: administration of ginger capsules contain 1000 mg drug with 30 cc water 1 hour before surgery. Intervention 2: Control: administration of placebo capsule with 30 cc wat
Treatment - Drugs
Intervention 1: administration of ginger capsules contain 1000 mg drug with 30 cc water 1 hour before surgery
Control: administration of placebo capsule with 30 cc water 1 hour before surgery
Intervention 2: administration of Ondansetron capsules contain 16 mg drug with 30 cc water 1 hour before surgery

Sponsors

Vice chancellor for research of Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Lack of cancer; Age 18 to 60 years; Ability to swallow capsules used in the study; Platelet count above 100 thousand; Not suffering from intestinal obstruction and hepatitis; Not pregnant; Absence epilepsy, diabetes and kidney disease; Lack of anti-emetic drugs; Lack of long-term treatment with corticosteroids; No history of allergy to ginger or ondansetron Exclusion Criteria: Severe nausea and vomiting after surgery and require to use antisemitic

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nausea. Timepoint: 2,4,6 hours after surgery. Method of measurement: Using a Check lists and standard tools.;Vomiting. Timepoint: 2,4,6 hours after surgery. Method of measurement: Using a Check lists and standard tools.

Secondary

MeasureTime frame
Cramp. Timepoint: 2, 4, 6 hours after surgery. Method of measurement: Visual analysis and Scoring.;Heartburn. Timepoint: 2, 4, 6 hours after surgery. Method of measurement: Visual analysis and Scoring.;Dyspenia. Timepoint: 2, 4, 6 hours after surgery. Method of measurement: Visual analysis and Scoring.;Diarrhea. Timepoint: 2, 4, 6 hours after surgery. Method of measurement: Visual analysis and Scoring.;Insomnia. Timepoint: 2, 4, 6 hours after surgery. Method of measurement: Visual analysis and Scoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Moradi Majd

Iran University of Medical Sciences

moradimajd.p@gmail.com+98 21 8670 4727

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026